Health

FDA Approves Skytrofa (lonapegsomatropin-tcgd) for the Once-Weekly Treatment of Adults with Growth Hormone Deficiency

DailyTrendDailyTrend
Jul 29, 2025 - 14:00
 0  0
FDA Approves Skytrofa (lonapegsomatropin-tcgd) for the Once-Weekly Treatment of Adults with Growth Hormone Deficiency
COPENHAGEN, Denmark, July 28, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the U.S. Food & Drug Administration (FDA) has approved Skytrofa (lonapegsomatropin-tcgd; developed as TransCon hGH) for the...
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
DailyTrend
DailyTrend

Related Posts

Mobile Lift Component Recall: Baxter Healthcare Corporation Removes Mobile Lift Component due to Risk of Improper Attachment

Mobile Lift Component Recall: Baxter Healthcare Corpora...

DailyTrend Jul 24, 2025  0  0

Is the Bread in Europe Better for You?

Is the Bread in Europe Better for You?

DailyTrend Jul 25, 2025  0  0

C.D.C. Ties 85 Cases of THC-Related Symptoms to Wiscons...

DailyTrend Jul 28, 2025  0  0

UnitedHealth Grew to Be a Leviathan. Then Came the Backlash.

UnitedHealth Grew to Be a Leviathan. Then Came the Back...

DailyTrend Jul 28, 2025  0  0

Disposable Surgical Stapler Cartridge Correction: Ethicon Endo-Surgery, LLC Issues Correction for Endopath Echelon to Address Inadvertent Lockout During Surgical Procedures

Disposable Surgical Stapler Cartridge Correction: Ethic...

DailyTrend Jul 26, 2025  0  0

Infection From Brain-Eating Amoeba Kills Boy in South C...

DailyTrend Jul 27, 2025  0  0